Financials Shanghai Rongtai Health Technology Corporation Limited

Equities

603579

CNE100002R81

Appliances, Tools & Housewares

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
23.26 CNY +2.20% Intraday chart for Shanghai Rongtai Health Technology Corporation Limited -0.51% +11.67%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,310 4,114 4,478 2,731 2,825 3,101 - -
Enterprise Value (EV) 1 4,310 4,114 4,478 2,731 2,825 3,101 3,101 3,101
P/E ratio 14.6 x 21.4 x 19.7 x 16.3 x 14.2 x 13.5 x 11.7 x 10.3 x
Yield 4.82% 1.66% 2.1% 2.5% 4.8% 4.99% 2.71% -
Capitalization / Revenue 1.86 x 2.04 x 1.71 x 1.36 x 1.52 x 1.5 x 1.29 x 1.12 x
EV / Revenue 1.86 x 2.04 x 1.71 x 1.36 x 1.52 x 1.5 x 1.29 x 1.12 x
EV / EBITDA 10.8 x 16.2 x - 10.5 x 9.24 x 9.55 x 8.47 x 7.66 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.67 x 2.61 x - 1.53 x 1.47 x 1.54 x 1.39 x 1.33 x
Nbr of stocks (in thousands) 138,594 136,370 134,305 136,625 135,626 133,320 - -
Reference price 2 31.10 30.17 33.34 19.99 20.83 23.26 23.26 23.26
Announcement Date 3/26/20 4/22/21 4/21/22 4/6/23 4/15/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,314 2,021 2,613 2,005 1,855 2,072 2,412 2,757
EBITDA 1 400.1 253.4 - 259.2 305.7 324.7 366.3 405
EBIT 1 326.9 200.4 - 186.5 236 272 316.7 357
Operating Margin 14.13% 9.92% - 9.3% 12.72% 13.13% 13.13% 12.95%
Earnings before Tax (EBT) 1 327.8 198.2 - 179.4 230.2 269.5 314.3 351
Net income 1 295.6 193 236.3 164.2 202.7 239.8 276.8 314
Net margin 12.77% 9.55% 9.05% 8.19% 10.93% 11.57% 11.48% 11.39%
EPS 2 2.130 1.410 1.690 1.230 1.470 1.725 1.993 2.260
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 1.500 0.5000 0.7000 0.5000 1.000 1.160 0.6300 -
Announcement Date 3/26/20 4/22/21 4/21/22 4/6/23 4/15/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 18.9% 12.1% - 9.08% 10.5% 11.6% 12% 12.9%
ROA (Net income/ Total Assets) 12.8% 7.13% - 4.9% 5.99% 6.93% 6.96% 7.34%
Assets 1 2,314 2,706 - 3,351 3,384 3,460 3,978 4,277
Book Value Per Share 2 11.60 11.50 - 13.00 14.20 15.10 16.70 17.50
Cash Flow per Share 2 3.190 1.970 2.410 1.690 2.480 2.380 2.510 -
Capex 1 151 185 134 96.3 86.8 110 114 77
Capex / Sales 6.51% 9.15% 5.12% 4.8% 4.68% 5.32% 4.71% 2.79%
Announcement Date 3/26/20 4/22/21 4/21/22 4/6/23 4/15/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
23.26 CNY
Average target price
26.02 CNY
Spread / Average Target
+11.89%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603579 Stock
  4. Financials Shanghai Rongtai Health Technology Corporation Limited